🐯Stalecollected in 18m

Hassabis Nobel, Gemini 3 Leads, AGI by 2030?

Hassabis Nobel, Gemini 3 Leads, AGI by 2030?
PostLinkedIn
🐯Read original on 虎嗅

💡DeepMind: Gemini 3 #1 multimodal, AlphaGenome 98% genome decode, AGI 50% 2030.

⚡ 30-Second TL;DR

What Changed

Gemini 3 released Nov 2025, excels in logic & multimodal interaction.

Why It Matters

Advances bio-AI for drug discovery/genomics; high AGI bar shapes research agendas and investments. Influences shift from LLMs to reinforcement learning paths.

What To Do Next

Test AlphaGenome on DeepMind platform for mutation impact predictions.

Who should care:Researchers & Academics

Key Points

  • Gemini 3 released Nov 2025, excels in logic & multimodal interaction.
  • AlphaGenome decodes 98% human genome, predicts mutations at 90% accuracy.
  • Hassabis forecasts 50% AGI probability by 2030 with science hypothesis ability.
  • AlphaFold 3 predicts biomolecules; Nobel for structure prediction.
  • DeepMind merges Google Brain in 2023 under Hassabis leadership.

🧠 Deep Insight

Background and context from public sources — not the original article. 6 sources cited.

🔑 Enhanced Key Takeaways

  • AlphaFold2, released in 2020, predicted structures for virtually all 200 million known proteins and has been accessed by over two million researchers in 190 countries.[3]
  • DNDi utilized AlphaFold as early adopters to accelerate drug discovery for neglected diseases like Chagas disease and leishmaniasis.[1]
  • EMBL-EBI integrated AlphaFold2 predictions into the public Protein Structure Database, enabling over one million users worldwide and thousands of citing papers.[5]
  • DeepMind spun out Isomorphic Labs a couple of years ago to apply AlphaFold technology to reimagine AI-driven drug discovery from first principles.[4]

🔮 Future ImplicationsAI analysis grounded in cited sources

AlphaFold enables AI-accelerated drug discovery for infectious diseases
DNDi and Isomorphic Labs are using AlphaFold to innovate treatments for neglected diseases and redesign drug discovery processes.[1][4]
Open AlphaFold database drives global research impact
EMBL-EBI's integration has led to over one million users and thousands of papers, unlocking insights into biology via public data.[5]

Timeline

2020-12
AlphaFold2 achieves breakthrough in protein structure prediction, topping CASP14 competition.
2023-04
DeepMind merges with Google Brain under Hassabis leadership.
2024-10
Demis Hassabis and John Jumper awarded 2024 Nobel Prize in Chemistry for AlphaFold protein structure prediction.
📰

Weekly AI Recap

Read this week's curated digest of top AI events →

👉Related Updates

AI-curated news aggregator. All content rights belong to original publishers.
Original source: 虎嗅

This is a summary, not the original. Read the source, or get the weekly briefing.

Weekly AI briefing

One email a week. Unsubscribe anytime.